Research report: Prognostic value of the neutrophil-to-lymphocyte ratio (NLR) in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: real-world data from Vietnam
A retrospective study of 233 patients with advanced hepatocellular carcinoma in Vietnam found that a pretreatment neutrophil-to-lymphocyte ratio of 3.6 ...




















